# The Effect of Botulinum Toxin A on Headache Attributed to TMD

> **NCT03346252** · EARLY_PHASE1 · COMPLETED · sponsor: **State University of New York at Buffalo** · enrollment: 20 (actual)

## Conditions studied

- Secondary Headache Disorder

## Interventions

- **DRUG:** Botulinum Toxin type A

## Key facts

- **NCT ID:** NCT03346252
- **Lead sponsor:** State University of New York at Buffalo
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-08
- **Primary completion:** 2021-03-15
- **Final completion:** 2021-03-15
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2022-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03346252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03346252, "The Effect of Botulinum Toxin A on Headache Attributed to TMD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03346252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*